Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

GLP-1 receptor agonists may cause hair loss, but more research is needed.

The conclusion is that there's a link between high testosterone levels, insulin resistance, and certain skin conditions, regardless of obesity.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

CTP-543 is generally safe for treating alopecia areata.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Hair disorders in organ transplant patients are often underestimated and need more attention and research.

Mutations in the POC1A gene can cause a unique form of extreme insulin resistance and short stature.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Immunological treatment improved both neuropathy and alopecia.

A woman experienced severe side effects from a drug due to a specific genetic variation, suggesting genetic testing could prevent such risks.

Skin issues from chronic graft-versus-host disease greatly affect daily life, needing teamwork between blood and skin doctors.

Trichothiodystrophy can be linked to urologic issues and high calcium in urine.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Retinoic acid, glucocorticoids, and IGF1 increase IGFBP-3 production in human dermal papilla cells, affecting hair growth.

Using a higher concentration of triamcinolone acetonide leads to faster hair regrowth in scalp patchy alopecia areata.

Adults with Beta Thalassemia Major are more likely to have skin, hair, and nail disorders.

Doctors used to view PCOS too narrowly, but now understand that insulin resistance is a key factor in the condition.

The patient's hair loss from alopecia totalis returned despite initial successful treatment.

Skin problems in patients with polycystic ovarian disease are linked to body weight, blood sugar, and hormone levels.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

The hydrogel treatment speeds up healing of diabetic wounds.

DNMT1 may help treat hypospadias by improving cell function and preventing unwanted cell changes.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.